SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-14-017069
Filing Date
2014-09-16
Accepted
2014-09-15 17:33:35
Documents
7
Period of Report
2014-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ahro20140915_8k.htm 8-K 38962
2 EXHIBIT 10.1 ex10-1.htm EX-10 186182
3 EXHIBIT 10.2 ex10-2.htm EX-10 71840
4 EXHIBIT 10.3 ex10-3.htm EX-10 95437
5 EXHIBIT 10.4 ex10-4.htm EX-10 212468
6 EXHIBIT 10.5 ex10-5.htm EX-10 50641
7 EXHIBIT 10.6 ex10-6.htm EX-10 82364
  Complete submission text file 0001437749-14-017069.txt   739465
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Filer) CIK: 0001377053 (see all company filings)

IRS No.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52315 | Film No.: 141104028
SIC: 2834 Pharmaceutical Preparations